integrative 1
computational 1
approach 1
prioritization 1
genomic 1
variants 1
combination 1
ibrutinib 1
rituximab 1
cyclophosphamide 1
doxorubicin 1
vincristine 1
prednisone 1
rchop 1
treatmentnaive 1
patients 1
cdpositive 1
bcell 1
nonhodgkin 1
lymphoma 1
nonrandomised 1
phase 1
b 1
study 1
